Anticoagulant-induced Bleeding Clinical Trial
Official title:
Artificial Intelligence-based Social Software Management Model to Improve Warfarin Anticoagulation Therapy: a Prospective, Single-blind, Randomized Control Trial
The investigators have demonstrated that social software could improve warfarin therapy quality by Human management. however,the efficiency of management will decline if patients' number expands huge. So it is needed that a human-like and automatic management tool could replace the human work. The aim of this study is to evaluate whether an AI-based social software management model could replace human to guide warfarin therapy.
1. The investigators have developed an AI-based miniprogram, and embedded in the Wechat
social application.
2. The investigators invited patients receiving warfarin therapy to participant this
randomized controlled trial .
3. Participants were randomized to the experimental group and control group in a ratio of
1:1.
4. Participants' warfarin therapy were managed by an AI-based social miniprogram and a
Human-based social miniprogram respectively.
5. International normalized ratio(INR) was monitored once a month at least, and the time in
therapeutic range was calculated to evaluate the warfarin anticoagulation quality.
6. Participants were followed-up for 24 months, and clinical events, including major
bleedings and thrombotic events were recorded during follow-up.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05563714 -
Anticoagulation With Enhanced Gastrointestinal Safety
|
N/A | |
| Completed |
NCT04046952 -
Comparing TR Band to Statseal in Conjunction With TR Band II
|
N/A | |
| Recruiting |
NCT04263038 -
Clinical Surveillance vs. Anticoagulation for Low-risk Patients With Isolated Subsegmental Pulmonary Embolism
|
Phase 4 | |
| Recruiting |
NCT04997265 -
Strategies for Anticoagulation During Venovenous ECMO
|
N/A | |
| Withdrawn |
NCT03399305 -
Safety and Efficacy of Apixaban in Severe Renal Impairment
|
||
| Withdrawn |
NCT04002011 -
DOAC Versus VKA After Cardiac Surgery
|
Phase 2 | |
| Recruiting |
NCT05290857 -
Anticoagulation After GI Bleeding Pilot Study and Registry
|
N/A | |
| Active, not recruiting |
NCT04878497 -
Prospective Monitoring of Non-Vitamin K Oral Anticoagulants in Older Adults With Atrial Fibrillation and Frailty
|
||
| Completed |
NCT05804734 -
Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia
|
||
| Completed |
NCT04662515 -
NOACs in Oral and Maxillofacial Surgery: Impact on Post-operative Complications
|
||
| Recruiting |
NCT03186729 -
Study of Antithrombotic Treatment After IntraCerebral Haemorrhage
|
Phase 4 | |
| Completed |
NCT05515120 -
Rivaroxaban Plus Aspirin to Manage Recurrent Venous Thromboembolic Events
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04291287 -
Triple or Dual Antithrombotic Therapy After PCI (TRIDUAL-PCI) Coronary Intervention in Patients With Non-valvular Atrial Fibrillation. Real-world Italian Multicenter Registry (TRIDUAL-PCI)
|
||
| Unknown status |
NCT01478282 -
Reversal of the Antithrombotic Action of New Oral Anticoagulants
|
Phase 4 | |
| Completed |
NCT03028025 -
Comparing TR Band to Statseal in Conjunction With TR Band
|
N/A | |
| Completed |
NCT03772613 -
The Randomized OPTIMAL-ACT Trial
|
Phase 2 | |
| Recruiting |
NCT05079295 -
Management of Anticoagulants and Antithrombotics in Patients With CSDH
|
||
| Enrolling by invitation |
NCT03244020 -
LMWH vs Aspirin for VTE Prophylaxis in Orthopaedic Oncology
|
Phase 4 | |
| Completed |
NCT04397289 -
Anticoagulation Therapy After Splenectomy in Cirrhosis Patient
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06232278 -
Long-term Results of Percutaneous Left Atrial Closure at Brest University Hospital (CLAPOT)
|